Ticker: CRSP

Company: CRISPR Therapeutics AG

Person: JAMES R KASINGER, officer

Transaction date: Feb. 18, 2026

Reporting date: Feb. 20, 2026

Average share price: -64.82718038528897

Sold 1713.0 shares for 111048.96